Down-regulated DEGs in recGBM were involved in cell proliferation (EGFR) and possibly brain tumor cell growth (BCAN), deadenylation of mRNA, which is linked to neurodevelopmental disorders (CNOT2), multi-drug resistance (ABCG2), and immune-related processes (GZMK). This evidence concerns the gene EGFR and neurodevelopmental disorder.